GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- B4953 Methylprednisolone Sodium SuccinateTarget: Glucocorticoid ReceptorsSummary: glucocorticoid
- B5904 Regadenoson1 CitationTarget: Adenosine A2A ReceptorsSummary: Highly selective and low affinity A2A adenosine agonist
- B4575 AL 8810Target: prostaglandin FP receptorSummary: Antagonist of prostaglandin F2α (FP) receptor.
- B7818 ONO-7300243Target: LPASummary: LPA1 antagonist
- B1429 Rimonabant3 CitationTarget: CB1 Receptors|CB2 ReceptorsSummary: CB1 receptor antagonist
- B1198 CisaprideTarget: Voltage-gated Potassium (KV) Channels|5-HT4 ReceptorSummary: 5-HT4 receptor agonist
- B1926 Dexamethasone acetateTarget: Glucocorticoid Receptors|interleukin receptorSummary: IL Receptor modulator
- B2210 AzilsartanTarget: Angiotensin AT1 ReceptorsSummary: Potent angiotensin II type 1 (AT1) receptor inverse agonist
- B1070 AHU-377(Sacubitril)Target: neprilysinSummary: Neprilysin inhibitor
- B1007 AVE 09911 CitationTarget: Angiotensin AT1 ReceptorsSummary: Agonist of angiotensin-(1-7) receptor